What You Need to Know
The cardiovascular team at Jersey Shore University Medical Center recently implanted New Jersey’s first dual-chamber leadless pacemaker systems in patients, as part of Abbott’s AveirTM DR i2i clinical study.
Unlike traditional pacemakers, leadless pacemakers are implanted directly into the heart through a minimally invasive catheter-based procedure and eliminate the need for cardiac leads.
Electrophysiologist Mark Mascarenhas, M.D., implanted the first dual-chamber leadless pacemakers at Jersey Shore University Medical Center.
Medical device company Abbott designed their i2i technology to provide beat-by-beat communication between two leadless pacemakers, one positioned in the right ventricle and one positioned in the right atrium of the heart. This technology is designed to regulate the heart rate synchronously between chambers allowing for dual-chamber leadless pacing.